---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-289920"
form_type: "8-K"
ticker: "KLRS"
cik: "0001754068"
company_name: "Kalaris Therapeutics, Inc."
filed_at: "2022-11-21T23:59:59+00:00"
generated_at: "2026-06-21T15:09:12.774890+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# AlloVir announces resignation of Chief Commercial Officer Jeroen van Beek effective Nov 23

## Summary
- EVP and CCO Jeroen van Beek resigns Nov 23, 2022 to pursue new opportunities; will consult through Dec 31.
- Company begins search for new head of Commercial organization.
- Separation benefits: lump sum base salary through Dec 31, 2022, 2022 cash bonus, COBRA through Nov 23, 2023, and accelerated vesting of options/RSUs vesting by Dec 31, 2022.
- Separation Agreement includes non-competition, confidentiality, and non-solicitation covenants.

## SEC filing metadata
- accession: 0001193125-22-289920
- form_type: 8-K
- ticker: KLRS
- cik: 0001754068
- company_name: Kalaris Therapeutics, Inc.
- filed_at: 2022-11-21T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1754068/000119312522289920/0001193125-22-289920-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1754068/000119312522289920/d368771d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-289920
- JSON: https://secwatch.observer/filing/0001193125-22-289920.json
- Plain text: https://secwatch.observer/filing/0001193125-22-289920.txt

## Key facts
- Executive change
  Jeroen van Beek resigned as Executive Vice President and Chief Commercial Officer at Kalaris Therapeutics, Inc..
  - Action: resigned
  - Role: Executive Vice President and Chief Commercial Officer
  source text: On November 21, 2022, AlloVir, Inc. (“AlloVir” or the “Company”) announced that Jeroen van Beek, the Company’s Executive Vice President and Chief Commercial Officer, has resigned from the Company effective as of November 23, 2022 to pursue new opportunities.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1754068/000119312522289920/0001193125-22-289920-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.